Anti-double-stranded DNA antibodies in the healthy elderly: Prevalence and characteristics
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Using Crithidia luciliae fluorescent assay a significant prevalence (7.6%; P less than 0.006) of anti-double-stranded DNA antibodies was found in a healthy old population. A negative enzyme-linked immunosorbent assay for anti-total histone antibodies excluded a false-positive reaction. Anti-double-stranded DNA antibodies in the aged differed from those found in patients with systemic lupus erythematosus and were characterized by a low titer (95.6% of cases), belonging to the IgA class alone (95.6%), no complement-fixing ability (100%), and negativity to Farr assay (100%). It is concluded that, in elderly subjects without signs and symptoms of disease, including systemic lupus erythematosus, such a peculiar anti-double-stranded DNA antibody may be detected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple forms of cytoDNA may be secreted and act as a cell non-autonomous signal in physiology and disease, which has been proposed as a biomarker for sterile inflammation (Ruffatti et al., 1990).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Ruffatti et al., 1990
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · cited 1×
“For comparison, the sera of 38 patients (4 men and 34 women, aged between 13 and 58 years; mean age, 36.6 years) affected with SLE were also screened. They fulfilled the ARA criteria ( 21 ).”
InfluentialAdmission criteria for immunogerontological studies in man: The senieur protocol
Ligthart, G. J., Corberand, J. X., Fournier, C., Galanaud, P., Hijmans, W., Kennes, B., Müller-Hermelink, H. K., & Steinmann, G. G. (1984) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(84)90152-0 · Cited by 754 · cited 1×
“All lived in old people's homes and were selected according to the SENIEUR protocol for immunogerontological studies in man (19).”
High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.
Manoussakis, M. N., Tzioufas, A. G., Silis, M. P., Pange, P. J. E., Goudevenos, J. A., & Moutsopoulos, H. Μ. (1987) · PubMed · Cited by 339
Lymphocyte Phytohemagglutinin Responsiveness, Immunoglobulins and Autoantibodies in Aging Humans
Hallgren, H. M., Buckley, C. E., Gilbertsen, V. A., & Yunis, E. J. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.111.4.1101 · Cited by 282 · cited 1×
“It is also interesting to stress that the striking prevalence of IgA isotype may be in keeping with increased levels of IgA immunoglobulins described in the healthy aged (15, 25, 26).”
Tan, E. M., Chan, E. K. L., Sullivan, K. F., & Rubin, R. L. (1988) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(88)90066-9 · Cited by 271 · cited 1×
“They are highly specific for SLE, rarely being found in patients with other disorders, especially at high titers (1).”
The first international standard for antibodies to double stranded DNA
Feltkamp, T. E., Kirkwood, T. B., Maini, R. N., & Aarden, L. A. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.9.740 · Cited by 97
Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.
Smeenk, R., van der Lelij, G., & Aarden, L. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.1.73 · Cited by 90 · cited 1×
“Moreover, it may be assumed that the Crithidia-positive sera of the elderly, being negative to Farr assay, are the low-avidity antidsDNA antibodies; in fact, the Fan" assay is considered a suitable method for detection only of high-avidity antibodies (10).”
Aarden, L. A., Lakmaker, F., & Feltkamp, T. E. W. (1976) · Journal of Immunological Methods · doi:10.1016/0022-1759(76)90004-1 · Cited by 73
CHUBICK, A., SONTHEIMER, R. D., GILLIAM, J. N., & ZIFF, M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-2-186 · Cited by 55
Autoantibodies to intracellular proteins
Christian, C. L., & Elkon, K. B. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90048-3 · Cited by 53
Autoantibodies and Their Relation to Rheumatic Diseases
McCarty, G. A. (1986) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30952-x · Cited by 45
PLATELET ALPHA GRANULE PROTEINS IN STROKE AND TRANSIENT ISCHAEMIC ATTACKS
O'Brien, J. R., & Etherington, M. D. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92158-5 · Cited by 43
Ballou, S. P., & Kushner, I. (1979) · PubMed · Cited by 42
Drug-related lupus. Clinical and etiologic considerations.
Solinger, A. M. (1988) · PubMed · Cited by 40
Solinger, A. M. (1988) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00954-6 · Cited by 38
Occult Systemic Lupus Erythematosus in Elderly Men
Baer, A. N. (1983) · JAMA · doi:10.1001/jama.1983.03330480056031 · Cited by 36 · cited 2×
“using an enzyme-linked immunosorbent assay (15), although other researchers did not detect Ihem using RIA (16, 17) or an indirect immunoperoxidase test (18).”
Antinuclear Antibodies in Autoimmune Disease: Significance and Pathogenicity
HARMON, C. E. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31032-x · Cited by 31
Smeenk, R. J. T., Swaak, T. J. G., & Smeenk, R. J. T. (1987) · Clinical Rheumatology · doi:10.1007/bf02200721 · Cited by 27 · cited 1×
“A number of studies (2-6) have emphasized that not only the concentration of dsDNA antibodies but also other properties such as immunoglobulin class, complement-fixing ability, and antigen avidity are important with respect to the pathogenesis of tissue damage and the clinical features of SLE.”
Deng, J.-S., Rubin, R. L., Lipscomb, M. F., Sontheimer, R. D., & Gilliam, J. N. (1984) · American Journal of Clinical Pathology · doi:10.1093/ajcp/82.4.448 · Cited by 26 · cited 1×
“The antigenic composition of the kinetoplast of Crithidia has been questioned (14), the contention being that it contains minute amounts of histones or histonelike antigens.”
FAILURE TO DETECT AGE-RELATED INCREASE OF NON-PATHOLOGICAL AUTOANTIBODIES
Gordon, J., & Rosenthal, M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92157-3 · Cited by 19 · cited 1×
“using an enzyme-linked immunosorbent assay (15), although other researchers did not detect Ihem using RIA (16, 17) or an indirect immunoperoxidase test (18).”
Parker, M. D., & Turner, R. A. (1976) · Arthritis & Rheumatism · doi:10.1002/art.1780190504 · Cited by 15 · cited 1×
“The complement-fixing ability of antidsDNA antibodies was investigated according to Parker and Turner (22).”
A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
Mc, C., Carr, R. I., Nm, B., Zy, C., & Sk, A. (1986) · PubMed · Cited by 14
Immunological studies in human ageing. II. Associated increase in anti-RNA and anti-DNA antibodies.
Schuller, E., Allinquant, B., Reboul, J., Fournier, C., Dardenne, M., & Bach, J. (1981) · PubMed · Cited by 13
Polynucleotide antibodies in connective tissue disease: viral markers or disease mediators?
Spencer-Green, G., Kelley, L., Adams, L. E., Donovan‐Brand, R., & Hess, E. V. (1986) · PubMed · Cited by 12
ANTI‐DNA ANTIBODIES: THE CHOICE OF ASSAYS FOR ROUTINE DIAGNOSTIC WORK
Sarvas, H. O., Gripenberg, M., & Leirisalo‐Repo, M. (1985) · Acta Pathologica Microbiologica Scandinavica Section C Immunology · doi:10.1111/j.1699-0463.1985.tb02915.x · Cited by 9 · cited 1×
“The two most commonly applied techniques for detection of anti-dsDNA antibodies are the Farr radioimmunoassay and the Crithidia luciliae immunofluorescence assay (5, 7-10 ).”
Antibodies to Nuclear and Other Intracellular Antigens in the Connective Tissue Diseases
Alarcón-Segovia, D. (1983) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00450-1 · Cited by 7
Mechanisms of Antinuclear Antibody Production in the Rheumatic Diseases
Pisetsky, D. S. (1987) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00934-0 · Cited by 6
Cited by
The use of laboratory tests in the diagnosis of SLE
Egner, W. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.6.424 · Cited by 316
Cytoplasmic DNA: sources, sensing, and role in aging and disease
Miller, K. N., Victorelli, S. G., Salmonowicz, H., Dasgupta, N., Liu, T., Passos, J. F., & Adams, P. D. (2021) · Cell · doi:10.1016/j.cell.2021.09.034 · Cited by 288
Serum antibodies in epilepsy and seizure-associated disorders
McKnight, K., Jiang, Y., Hart, Y., Cavey, A., Wroe, S., Blank, M., Shoenfeld, Y., Vincent, A., Palace, J., & Lang, B. (2005) · Neurology · doi:10.1212/01.wnl.0000187129.66353.13 · Cited by 231
Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody tests
Kavanaugh, A. F., Solomon, D. H., & The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines (2002) · Arthritis Care & Research · doi:10.1002/art.10558 · Cited by 225
Patel, D. R., & Richardson, B. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00132-7 · Cited by 158
Metadata
- Authors
- Ruffatti, A., Calligaro, A., Del Ross, T., Bertoli, M. T., Doria, A., Rossi, L., & Todesco, S. V.
- Affiliations
- University of Padua (IT)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- Venue
- Journal of Clinical Immunology
- Published
- 1990-11
- Volume
- 10
- Issue
- 6
- Pages
- 300-303
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W1997089878
- Cited by
- 41
- References
- 27
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 2 · 2020: 1 · 2019: 5 · 2018: 1 · 2016: 2 · 2015: 1 · 2013: 2 · 2012: 2
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- anti-dsDNA antibodies, healthy older adults, prevalence, systemic lupus erythematosus, IgA antibodies, complement fixation, Farr assay, autoantibodies
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Antibodies, Antinuclear, Complement Fixation Tests, DNA, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, Male, Radioimmunoassay, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.